-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier: Passage Bio Initiates Strategic Review, Exploring Mergers, Acquisitions, Partnerships, And Other Options To Maximize Shareholder Value

Benzinga·04/20/2026 13:00:24
Listen to the news

Corporate Update

The Company has initiated a review of strategic alternatives to maximize shareholder value. These strategic alternatives may include merger or acquisition transactions, a reverse merger, a sale of assets of the Company, strategic partnerships, licensing opportunities, or other potential paths.

The strategic review is underway, and the Company does not intend to provide updates until the Board approves a specific action or otherwise determines that disclosure is appropriate or required. There can be no assurance that the process will result in any such transaction.

The Company has engaged Wedbush PacGrow as a financial advisor to assist in the strategic review process.